These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8985478)

  • 21. The eosinophil.
    Jones DG
    J Comp Pathol; 1993 May; 108(4):317-35. PubMed ID: 8366200
    [No Abstract]   [Full Text] [Related]  

  • 22. Eosinophil major basic protein: first identified natural heparanase-inhibiting protein.
    Temkin V; Aingorn H; Puxeddu I; Goldshmidt O; Zcharia E; Gleich GJ; Vlodavsky I; Levi-Schaffer F
    J Allergy Clin Immunol; 2004 Apr; 113(4):703-9. PubMed ID: 15100677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of eosinophils generated in vitro from CD34+ peripheral blood progenitor cells.
    Rosenberg HF; Dyer KD; Li F
    Exp Hematol; 1996 Jul; 24(8):888-93. PubMed ID: 8690047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis.
    Yamazaki K; Suzuki K; Nakamura A; Sato S; Lindor KD; Batts KP; Tarara JE; Kephart GM; Kita H; Gleich GJ
    Hepatology; 1999 Jul; 30(1):71-8. PubMed ID: 10385641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
    Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
    J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary eosinophilic syndromes.
    Enright T; Chua S; Lim DT
    Ann Allergy; 1989 Apr; 62(4):277-83. PubMed ID: 2650585
    [No Abstract]   [Full Text] [Related]  

  • 27. Pitfalls in the quantitative estimation of the secretion of granule proteins by eosinophils.
    Bach MK; Brashler JR; Sanders ME; Bienkowski MJ
    J Immunol Methods; 1991 Sep; 142(2):243-50. PubMed ID: 1919027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization.
    Davis MD; Plager DA; George TJ; Weiss EA; Gleich GJ; Leiferman KM
    J Allergy Clin Immunol; 2003 Nov; 112(5):988-94. PubMed ID: 14610493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathological study of eosinophils in eosinophilic granuloma of bone: evidence for release of three cationic proteins and subsequent uptake in macrophages.
    Janin A; Torpier G; Capron M; Courtin P; Gosselin B
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):255-61. PubMed ID: 1413491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytophilic and cytotoxic properties of human eosinophil peroxidase plus major basic protein.
    Samoszuk MK; Petersen A; Gidanian F; Rietveld C
    Am J Pathol; 1988 Sep; 132(3):455-60. PubMed ID: 3414778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of the human eosinophil Charcot-Leyden crystal protein (lysophospholipase) gene (CLC) to chromosome 19 and the human ribonuclease 2 (eosinophil-derived neurotoxin) and ribonuclease 3 (eosinophil cationic protein) genes (RNS2 and RNS3) to chromosome 14.
    Mastrianni DM; Eddy RL; Rosenberg HF; Corrette SE; Shows TB; Tenen DG; Ackerman SJ
    Genomics; 1992 May; 13(1):240-2. PubMed ID: 1577491
    [No Abstract]   [Full Text] [Related]  

  • 32. Inflammatory cell activation by eosinophil granule proteins.
    Thomas LL; Page SM
    Chem Immunol; 2000; 76():99-117. PubMed ID: 10761307
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of human cysteine-rich secretory protein 3 (CRISP-3) as a matrix protein in a subset of peroxidase-negative granules of neutrophils and in the granules of eosinophils.
    Udby L; Calafat J; Sørensen OE; Borregaard N; Kjeldsen L
    J Leukoc Biol; 2002 Sep; 72(3):462-9. PubMed ID: 12223513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased microvascular permeability induced by eosinophil proteins.
    Minnicozzi M; Gleich GJ; Durán WN; Egan RW
    Int Arch Allergy Immunol; 1995; 107(1-3):348. PubMed ID: 7613168
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents.
    Ratnoff OD; Gleich GJ; Shurin SB; Kazura J; Everson B; Embury P
    Am J Hematol; 1993 Jan; 42(1):138-45. PubMed ID: 8416290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis.
    Sangfelt P; Carlson M; Thörn M; Lööf L; Raab Y
    Am J Gastroenterol; 2001 Apr; 96(4):1085-90. PubMed ID: 11316151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The eosinophil leukocyte: maturation and function.
    Butterfield JH; Maddox DE; Gleich GJ
    Clin Immunol Rev; 1983-1984; 2(2):187-306. PubMed ID: 6325060
    [No Abstract]   [Full Text] [Related]  

  • 38. Basophil and eosinophil interactions in health and disease.
    Thomas LL
    Chem Immunol; 1995; 61():186-207. PubMed ID: 7662143
    [No Abstract]   [Full Text] [Related]  

  • 39. Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen.
    Clark K; Simson L; Newcombe N; Koskinen AM; Mattes J; Lee NA; Lee JJ; Dent LA; Matthaei KI; Foster PS
    J Leukoc Biol; 2004 Jun; 75(6):1001-9. PubMed ID: 15020648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
    Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
    Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.